Earnings Feed
Start Free
Home/Filings/4/0001181431-05-009857
4//SEC Filing

BAKER BROS CAPITAL GP LLC 4

Accession 0001181431-05-009857

CIK 0000946840other
View on SEC.govCompany Profile

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 9:25 PM ET

Size

18.1 KB

Accession

0001181431-05-009857

Insider Transaction Report

Form 4
Period: 2005-01-28
VIROPHARMA INCVPHM
Baker Bros. Capital (GP), LLC
10% Owner
Transactions
  • Purchase

    Common Stock

    2005-01-31$3.02/sh+605$1,827→ 605 total(indirect: See Footnote)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+90,000→ 352,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (36,000 underlying)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+30,000→ 382,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (12,000 underlying)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-28+42,000→ 262,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (16,800 underlying)
BAKER FELIX
10% Owner
Transactions
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+90,000→ 352,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (36,000 underlying)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+30,000→ 382,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (12,000 underlying)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-28+42,000→ 262,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (16,800 underlying)
  • Purchase

    Common Stock

    2005-01-31$3.02/sh+605$1,827→ 605 total(indirect: See Footnote)
BAKER JULIAN
10% Owner
Transactions
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+90,000→ 352,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (36,000 underlying)
  • Purchase

    Common Stock

    2005-01-31$3.02/sh+605$1,827→ 605 total(indirect: See Footnote)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-28+42,000→ 262,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (16,800 underlying)
  • Purchase

    6.0% Convertible Senior Secured Notes due 2009

    2005-01-31+30,000→ 382,000 total(indirect: See Footnote)
    Exercise: $2.50Exp: 2009-10-18→ Common Stock (12,000 underlying)
Footnotes (14)
  • [F1]In addition to Baker Bros. Capital (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Bros. Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. However, the Reporting Persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
  • [F10]142% of the principal amount.
  • [F11]Represents 228,000 principal amount of notes owned directly by Baker Bros. Investments, L.P., and 124,000 principal amount of notes owned directly by Baker Bros. Investments II, L.P.
  • [F12]Represents 15,000 principal amount of notes purchased by Baker Bros. Investments, L.P., and 15,000 principal amount of notes purchased by Baker Bros. Investments II, L.P.
  • [F13]142.25% of the principal amount.
  • [F14]Represents 243,000 principal amount of notes owned directly by Baker Bros. Investments, L.P., and 139,000 principal amount of notes owned directly by Baker Bros. Investments II, L.P.
  • [F2]Represents 308 shares of common stock purchased by Baker Bros. Investments, L.P., and 297 shares of common stock purchased by Baker Bros. Investments II, L.P.
  • [F3]Represents 308 shares of common stock owned directly by Baker Bros. Investments, L.P., and 297 shares of common stock owned directly by Baker Bros. Investments II, L.P.
  • [F4]Represents shares and/or notes owned directly by Baker Bros. Investments, L.P., and shares of common stock owned directly by Baker Bros. Investments II, L.P. Baker Bros. Investments, L.P., and Baker Bros. Investments II, L.P., are each limited partnerships of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Bros. Capital (GP), LLC.
  • [F5]Represents 21,000 principal amount of notes purchased by Baker Bros. Investments, L.P., and 21,000 principal amount of notes purchased by Baker Bros. Investments II, L.P.
  • [F6]Immediately.
  • [F7]140% of the principal amount.
  • [F8]Represents 182,000 principal amount of notes owned directly by Baker Bros. Investments, L.P., and 80,000 principal amount of notes owned directly by Baker Bros. Investments II, L.P.
  • [F9]Represents 46,000 principal amount of notes purchased by Baker Bros. Investments, L.P., and 44,000 principal amount of notes purchased by Baker Bros. Investments II, L.P.

Documents

1 file

Issuer

VIROPHARMA INC

CIK 0000946840

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001244390

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:25 PM ET
Size
18.1 KB
View on SEC.gov